We are requesting the participation of patients who have suffered persistent health damage following use and discontinuation of certain drugs and substances with endocrine-disruptive properties (listed below).
NOTE: Current results can be found HERE.
Members can access their personal survey when logged in via the bar graph icon at the top right of the page when browsing on a desktop or laptop computer:
New members can register via the “Sign up” button at the top of the page and participate in the forum. Consider starting a topic in the member stories section to introduce yourself and share your story. After some participation in the forum you will be invited to participate in the survey.
This ambitious project is an unprecedented step for any patient community anywhere. It promises to generate vital data on post-drug disorders that will inform the scientific community and draw attention to this important public health issue. In addition to profiling the symptomatic condition of patients over time, it will gather further data including the impact on quality of life and patient’s satisfaction with clinical care. Contributing patients will be able to view reports generated from submitted data in the future.
As such, your time spent participating is valuable and deeply appreciated, whether you are an active participant or you are no longer visiting the forum. The more affected patients that complete the survey, the more powerful the data will be.
Please ask any further questions in this topic, but please first check to see if they are answered in the following FAQ or in a subsequent reply to this thread.
You are able to access your personal survey when logged into the forum on a desktop or laptop computer by clicking the bar graph icon in the top right of the page:
If you are a member who has been inactive since before the site relaunch, you may be considered a new user by our system. Please post in this thread to let a moderator know.
Users who have been excluded from participation in the forum for any reason, including breaches of site terms and conditions or abuse, are not eligible for the survey.
It is our view that no publication to date has assessed the true scope of this important public health issue. Novel factors, such as the common experience of patients worsening severely and permanently upon withdrawal of the medication, have not been adequately described in peer reviewed literature. The clinical profiles noted in medical publications thus far are often incomplete or selected by relevance to the research interest of the investigating clinician or scientist, resulting in misrepresentations of the syndrome’s extent. FAERS data suggests young patients adversely affected by 5ARI medications are substantially less likely than older patients to have their case reported to the FDA by their physicians, despite a greater association with disability in this group. This is reflected in the common anecdotal reports from patients of clinicians expressing disbelief, attributing symptoms to psychosomatic factors or failing to attribute new diagnoses or clinical findings to use of the causal medication.
The long history of the propeciahelp forum, spanning well over a decade, is the largest collection of patient experience of what is currently termed PFS. Until now, no one has been unable to present an accessible clinical profile and data-driven exploration of this novel, rare and poorly understood syndrome. Our survey aims to clarify patient experience in easily presented data for clinicians, scientists, patients and anyone else interested in the condition. Through understanding and acknowledgement of the true scope of the problem, future research can be better directed towards etiological understanding, which can pave the way for prevention through identification and screening of novel risk factors, effective treatment options, and ultimately a cure.
To participate in this survey you must be a patient suffering persistent health problems for at least three months following the use and cessation of a drug, substance, or drug/substance of a class in the following list:
- Finasteride (Propecia, Proscar, generics)
- Dutasteride (Avodart, Duodart, generics)
- Isotretinoin (Accutane, Roaccutane, generics)
- Antidepressant (various including SSRI class medications)
- GnRH analogue such as Leuprorelin (Lupron, Eligard), Goserelin (Zoladex), Triptorelin (Decapeptyl, Gonapeptyl)
- Androgen receptor antagonist (including Cyprotone acetate, Spironolactone, Bicalutamide, Enzalutamide, Abiraterone acetate, RU 58841)
- Saw Palmetto extract
- Phenolic compound supplement (including Milk Thistle, Resveratrol, Rutin, Genistein)
- Minoxidil (Rogaine, generics)
Additionally, patients may participate in the survey if they are members of the forum experiencing a similar persistent symptom profile to what is currently termed PFS after the use of other drugs or alternative therapies with endocrine-disruptive properties and have received prior consent from a propeciahelp moderator or administrator. Users who have been excluded from participation in the forum for any reason, including breaches of site terms and conditions or abuse, are not eligible for the survey.
You must be a registered user of the propeciahelp.com forum. We have created and integrated a system that will automatically assign you a unique invite to participate in the survey. PFS patients who are not currently registered here, or patients suffering persistent problems following use of the aforementioned drugs or substances, are welcome to register via the “Sign up” button at the top of the page. Registration and participation here requires agreeing to our Terms of Service which includes our community rules.
Once you have participated in the forum you will be issued a unique invitation by email to take part in the survey. An easy way to do this is to share your story in the member stories section and reply to a few topics. Please see the first section of this FAQ if you think you should have received an invite and have not.
Please allow at very least one hour. The survey is considerable length and detail. We believe the time investment will be worth it as it it will provide valuable data in an unprecedented manner. As such, the survey can be saved and resumed at a later date via your unique invite, so you do not need to complete it in one sitting.
The survey was developed by acting administrators of propeciahelp.com, @awor and @axolotl. It is the culmination of thousands of hours of focused work. Input was gratefully received from organising members and patients from the respective communities suffering potentially overlapping persistent post-drug health damage, including the PFS, PAS, PSSD and Lupron patient communities. It was based upon detailed consideration of the many years of patient reports, shared clinical findings, and published medical literature surrounding the syndromes. Feedback was additionally received from medical professionals including those who have produced publications centered on PFS. We acknowledge the inherent shortcomings of self-reporting and purposive non-random sampling, however every effort has been made to implement validated instruments, measures and established good practice standards of surveying wherever possible while ensuring the novel nature of the conditions are represented meaningfully. Custom code was provided by non-patient volunteers.
This survey is not designed to be taken on a mobile device. The survey was designed to be taken on a desktop or laptop computer.
No. Your answers will be linked internally to your forum account, but no personally identifiable information is requested in the survey.
The survey contains our data policy in full, and will ask for specific consents at the point of completion. This data will be compiled in aggregate form with other submissions and also as individually accessible data through an analytics platform that participants will have access to in the future. You will have the option as to whether your answers will be visibly tied to your forum account, or are included anonymously.
We have endeavoured to be thorough in our compilation of the broad and variable symptom profile caused by these drugs and substances. As well as consultation at the design stage, we conducted a beta test that included 17 PFS patients selected for differing symptoms and severity for individual feedback on both content and user experience. All feedback was carefully considered and much of this was implemented. However, it is entirely possible we have not included very rarely reported symptoms. To account for this, most sections conclude with free text boxes in which you can add comments.
Not everyone’s symptomatic experience of PFS is the same. In addition to the questions tailored to our variable condition, we have incorporated established scientific instruments where possible. As such, these must be completed in their entirety to adhere to their scoring systems and yield credible results. The survey includes the following validated instruments:
Rapid Disability Rating Scale (RDRS2)
The International Index of Erectile Function (IIEF)
The Female Sexual Function Index (FSFI)
Short Assessment of Patient Satisfaction (SAPS)
Depression Anxiety Stress Scale (DASS-21)
Yes, please do. The survey has multiple time frames to track changes in your condition.
I have a strongly held belief that none of these post-drug conditions are connected and therefore do not think these should be recorded together.
Submissions are recorded individually and aggregate data can be isolated by a variety of factors, including per-substance, at the analysis stage.
MrPipe, a forum user, told me to follow MrPipe’s cleansing protocol and it [helped/worsened] my symptoms. Can I report this?
Yes, separately to the main survey we have developed further systems for data reporting. A therapeutic reporting system is accessible through the forum that allows patients to report therapeutic outcomes, as well as notable responses to things not taken for therapeutic relief of their post-drug symptoms. A further system for reporting clinical test results is also provided, and can be continually editable should you have experience with a new therapy or recieve a new test result.
Both the therapeutic reporting and test reporting surveys are accessible once the main post-drug syndrome survey has been completed, and they can be accessed via the bar graph link in the top right of the forum when browsing on a desktop or laptop computer. The systems to display the results of submissions is still in development, but you can submit data in the meantime.
Please make a forum topic for speculation or theoretical discussions. This is not suitable or relevant data for the survey.
I would like to add questions to or make changes to the questions people are being asked in the survey.
The content of the survey is finalised. You may create a poll topic in the forum for your own queries.
For the purposes of data integrity, no - the survey will not be editable. However, the therapeutic outcome system is continually editable and the clinical test result system can be submitted for every date you have tests from. These can be accessed via the bar graph icon in the top right once you have completed the post-drug syndrome survey.
Reports will be generated from the data and made into individual topics in two dedicated subforums. One subforum will be public, while members who have participated will have access to a second forum where additional reports will be shared.
Please ask it by replying to this topic.